Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 6
2003 9
2004 11
2005 17
2006 16
2007 17
2008 9
2009 11
2010 18
2011 18
2012 20
2013 22
2014 22
2015 25
2016 29
2017 43
2018 45
2019 37
2020 35
Text availability
Article attribute
Article type
Publication date

Search Results

361 results
Results by year
Filters applied: . Clear all
Page 1
A Conversation Between Uwe Haberkorn and Johannes Czernin.
Haberkorn U, Czernin J. Haberkorn U, et al. J Nucl Med. 2019 Nov;60(11):1495-1498. doi: 10.2967/jnumed.119.236760. J Nucl Med. 2019. PMID: 31676705 Free article. No abstract available.
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.
Loktev A, Lindner T, Mier W, Debus J, Altmann A, Jäger D, Giesel F, Kratochwil C, Barthe P, Roumestand C, Haberkorn U. Loktev A, et al. Among authors: haberkorn u. J Nucl Med. 2018 Sep;59(9):1423-1429. doi: 10.2967/jnumed.118.210435. Epub 2018 Apr 6. J Nucl Med. 2018. PMID: 29626120 Free PMC article.
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.
Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, Adeberg S, Rathke H, Röhrich M, Winter H, Plinkert PK, Marme F, Lang M, Kauczor HU, Jäger D, Debus J, Haberkorn U, Giesel FL. Kratochwil C, et al. Among authors: haberkorn u. J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6. J Nucl Med. 2019. PMID: 30954939 Free PMC article.
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.
Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, Jäger D, Mier W, Haberkorn U. Lindner T, et al. Among authors: haberkorn u. J Nucl Med. 2018 Sep;59(9):1415-1422. doi: 10.2967/jnumed.118.210443. Epub 2018 Apr 6. J Nucl Med. 2018. PMID: 29626119 Free article.
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K. Kratochwil C, et al. Among authors: haberkorn u. Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544. doi: 10.1007/s00259-019-04485-3. Epub 2019 Aug 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 31440799
Targeting of activated fibroblasts for imaging and therapy.
Lindner T, Loktev A, Giesel F, Kratochwil C, Altmann A, Haberkorn U. Lindner T, et al. Among authors: haberkorn u. EJNMMI Radiopharm Chem. 2019 Jul 25;4(1):16. doi: 10.1186/s41181-019-0069-0. EJNMMI Radiopharm Chem. 2019. PMID: 31659499 Free PMC article. Review.
Consensus on molecular imaging and theranostics in prostate cancer.
Fanti S, Minozzi S, Antoch G, Banks I, Briganti A, Carrio I, Chiti A, Clarke N, Eiber M, De Bono J, Fizazi K, Gillessen S, Gledhill S, Haberkorn U, Herrmann K, Hicks RJ, Lecouvet F, Montironi R, Ost P, O'Sullivan JM, Padhani AR, Schalken JA, Scher HI, Tombal B, van Moorselaar RJA, Van Poppel H, Vargas HA, Walz J, Weber WA, Wester HJ, Oyen WJG. Fanti S, et al. Among authors: haberkorn u. Lancet Oncol. 2018 Dec;19(12):e696-e708. doi: 10.1016/S1470-2045(18)30604-1. Lancet Oncol. 2018. PMID: 30507436
68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.
Giesel FL, Kratochwil C, Lindner T, Marschalek MM, Loktev A, Lehnert W, Debus J, Jäger D, Flechsig P, Altmann A, Mier W, Haberkorn U. Giesel FL, et al. Among authors: haberkorn u. J Nucl Med. 2019 Mar;60(3):386-392. doi: 10.2967/jnumed.118.215913. Epub 2018 Aug 2. J Nucl Med. 2019. PMID: 30072500 Free PMC article.
Radionuclide Therapy of Metastatic Prostate Cancer.
Kratochwil C, Haberkorn U, Giesel FL. Kratochwil C, et al. Among authors: haberkorn u. Semin Nucl Med. 2019 Jul;49(4):313-325. doi: 10.1053/j.semnuclmed.2019.02.003. Epub 2019 Mar 2. Semin Nucl Med. 2019. PMID: 31227054 Review.
The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer.
Afshar-Oromieh A, Babich JW, Kratochwil C, Giesel FL, Eisenhut M, Kopka K, Haberkorn U. Afshar-Oromieh A, et al. Among authors: haberkorn u. J Nucl Med. 2016 Oct;57(Suppl 3):79S-89S. doi: 10.2967/jnumed.115.170720. J Nucl Med. 2016. PMID: 27694178 Free article. Review.
361 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback